Segmen Kardesler Gid Urt Ve Amblj Sny AS
SEGMN.IS
Istanbul Stock Exchange52.65
TRY
+1.50
- -
Segmen Kardesler Gid Urt Ve Amblj Sny AS
SEGMN.IS
(Istanbul Stock Exchange)
Recent
price
52.65
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Segmen Kardesler Gida Uretim Ve Ambalaj Sanayi AS (SEGMN.IS) manufactures and wholesales a wide range of packaged food products in Turkey, focusing on jams, honey, spreads, confectionery, and spices. The company produces fruit jams including diabetic, sugar-free, and probiotic varieties; honeys such as flower and pine honey; halva and diabetic halva; nut-based spreads like hazelnut cream, peanut butter, and biscuit spreads; tahini and molasses products including grape, mulberry, carob, and tahini-molasses mixes; Turkish delight (lokum); an assortment of spices encompassing red pepper flakes, black pepper, cumin, sesame, mint, sumac, and cinnamon; herbal teas; butter; purees and sauces; frozen fruits and vegetables; and contract-manufactured items such as cream cheese and triangular cheese. It operates four production facilities—three in Ankara and one in Afyonkarahisar—along with an accredited laboratory and regional directorates in Istanbul, Izmir, and Antalya, serving domestic markets through wholesale, retail, and online channels while exporting to international markets. Founded in 1938 by three brothers as a grocery store in Ankara, Turkey, where it maintains headquarters, the company transitioned to a collective enterprise in 1958 and expanded into modern manufacturing with facilities in Sincan Industrial Zone; it employs approximately 321 people under General Manager Okan Bayrak. Recent developments include sustained revenue growth to TRY 1.85 billion with 11.4% sales increase reported for fiscal year-end December 2025, alongside operational enhancements from a 2.36 MW rooftop solar power plant supporting energy needs and ongoing product diversification in health-oriented lines like sugar-free and probiotic offerings.